Clinical study of repaglinide efficacy and safety in type 2 diabetes mellitus patients with blood glucose levels inadequately controlled by sitagliptin

AIMS/INTRODUCTION: The aim of the present study was to evaluate the long‐term efficacy and safety of adding repaglinide in patients with type 2 diabetes mellitus whose blood glucose levels were not sufficiently controlled by treatment with a dipeptidyl peptidase‐4 inhibitor, sitagliptin, in addition...

Descripción completa

Detalles Bibliográficos
Autores principales: Kawamori, Ryuzo, Kaku, Kohei, Hanafusa, Toshiaki, Ioriya, Katsuhisa, Kageyama, Shigeru, Hotta, Nigishi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773675/
https://www.ncbi.nlm.nih.gov/pubmed/27042279
http://dx.doi.org/10.1111/jdi.12384

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773675/
https://www.ncbi.nlm.nih.gov/pubmed/27042279
http://dx.doi.org/10.1111/jdi.12384

Ejemplares similares